NFKB1 and breast carcinoma: Previous studies implicated both canonical and non-canonical NFκB activation in the regulation of breast cancer bone metastasis [10], and previous work by our laboratories has found that pharmacological inhibition of these pathways reduces the progression of breast cancer osteolytic metastatic [22].